Lactate aggravates myocardial Ischemia-Reperfusion injury through SLC39A14-mediated ferroptosis
Author:
Hua Xu1, Huang Xian-Xi2, He Ling-Bin1, Zhang Xin1
Affiliation:
1. Laboratory of Molecular Cardiology, The First Affiliated Hospital of Shantou University Medical College 2. Cardiology Department, The First Affiliated Hospital of Shantou University Medical College
Abstract
Abstract
Ferroptosis, a new form of iron-dependent regulated cell death, is driven by lipid peroxidation, playing a role in various pathogenic processes. Although the role of ferroptosis in myocardial ischemia-reperfusion injury (MIRI) has been intensively studied, the underlying molecular mechanisms remained largely unclear. Here, we showed that lactate participated in ferroptosis induced by hypoxia/reoxygenation in H9C2 cell. Importantly, hypoxia/reoxygenation induced apoptosis through aggravating ferroptosis by targeting NRF2/system Xc-/GPX4 axis, which reduced ROS scavenging. In addition, lactate promoted SLC39A14 expression followed by elevation of Fe2+ uptake, which generated superfluous ROS via the Fenton reaction. The excessive ROS could finally induce lipid peroxidation, thereby leading to ferroptosis characterized by cell apoptosis. Together, our findings suggest that lactate plays a crucial role as a novel regulator of ferroptosis, and reducing lactate levels might potentially offer a promising therapeutic strategy for managing myocardial ischemia-reperfusion injury.
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. 1. GBD 2017 Causes of Death Collaborators (2018) Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159):1736–1788 2. 2. Cung TT, Morel O, Cayla G, Rioufol G, Garcia-Dorado D, Angoulvant D, Bonnefoy-Cudraz E, Guérin P, Elbaz M, Delarche N, Coste P, Vanzetto G, Metge M, Aupetit JF, Jouve B, Motreff P, Tron C, Labeque JN, Steg PG, Cottin Y, Range G, Clerc J, Claeys MJ, Coussement P, Prunier F, Moulin F, Roth O, Belle L, Dubois P, Barragan P, Gilard M, Piot C, Colin P, De Poli F, Morice MC, Ider O, Dubois-Randé JL, Unterseeh T, Le Breton H, Béard T, Blanchard D, Grollier G, Malquarti V, Staat P, Sudre A, Elmer E, Hansson MJ, Bergerot C, Boussaha I, Jossan C, Derumeaux G, Mewton N, Ovize M (2015) Cyclosporine before PCI in Patients with Acute Myocardial Infarction. N Engl J Med 373(11):1021-31. 3. 3. Hausenloy DJ, Yellon DM (2013) Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest 123(1):92–100. 4. 4. Cao Y, Bojjireddy N, Kim M, Li T, Zhai P, Nagarajan N, Sadoshima J, Palmiter RD, Tian R (2017) Activation of γ2-AMPK Suppresses Ribosome Biogenesis and Protects Against Myocardial Ischemia/Reperfusion Injury. Circ Res 121(10):1182–1191. 5. 5. Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, Kang R, Tang D (2016) Ferroptosis: process and function. Cell Death Differ 23(3):369 − 79.
|
|